1. Market Research
  2. > Pharmaceutical
  3. > OTC Market Trends
  4. > Dermatologicals in Mexico

Dermatologicals in Mexico

  • September 2016
  • -
  • Euromonitor International
  • -
  • 31 pages

Dermatologicals, including antifungals, hair loss treatments, medicated shampoos, nappy (diaper) rash treatments, cold sore treatments and other dermatologicals, saw current value growth of 6% in 2016, to reach Mx$5.8 billion; it is the second largest OTC category in terms of value share after cough, cold and allergy (hay fever) remedies. Mexican consumers usually perceive dermatological conditions as minor maladies and trust OTC products as good options with which to treat them. In recent years...

Euromonitor International’s Dermatologicals in Mexico report offers a comprehensive guide to the size and shape of the market at a national level. It provides the latest retail sales data 2011-2015, allowing you to identify the sectors driving growth. Forecasts to 2020 illustrate how the market is set to change.

Product coverage: Antiparasitics/Lice (Head and Body) Treatments, Antipruritics, Cold Sore Treatments, Haemorrhoid Treatments, Hair Loss Treatments, Medicated Shampoos, Nappy (Diaper) Rash Treatments, Paediatric Dermatologicals, Topical Allergy Remedies/Antihistamines, Topical Antifungals, Topical Germicidals/Antiseptics, Vaginal Antifungals.

Data coverage: market sizes (historic and forecasts), company shares, brand shares and distribution data.

Why buy this report?
* Get a detailed picture of the Dermatologicals market;
* Pinpoint growth sectors and identify factors driving change;
* Understand the competitive environment, the market’s major players and leading brands;
* Use five-year forecasts to assess how the market is predicted to develop.

Table Of Contents

Dermatologicals in Mexico
DERMATOLOGICALS IN MEXICO
Euromonitor International
September 2016

LIST OF CONTENTS AND TABLES

Headlines
Trends
Competitive Landscape
Prospects
Category Data
Table 1 Sales of Dermatologicals by Category: Value 2011-2016
Table 2 Sales of Dermatologicals by Category: % Value Growth 2011-2016
Table 3 NBO Company Shares of Dermatologicals: % Value 2012-2016
Table 4 LBN Brand Shares of Dermatologicals: % Value 2013-2016
Table 5 LBN Brand Shares of Hair Loss Treatments: % Value 2013-2016
Table 6 Forecast Sales of Dermatologicals by Category: Value 2016-2021
Table 7 Forecast Sales of Dermatologicals by Category: % Value Growth 2016-2021
Bayer De Mexico SA De Cv in Consumer Health (mexico)
Strategic Direction
Key Facts
Summary 1 Bayer de Mexico Sa de CV: Key Facts
Competitive Positioning
Summary 2 Bayer de Mexico SA de CV: Competitive Position 2016
Boehringer Ingelheim Promeco SA De Cv in Consumer Health (mexico)
Strategic Direction
Key Facts
Summary 3 Boehringer Ingelheim Promeco SA de CV: Key Facts
Summary 4 Boehringer Ingelheim Promeco SA de CV: Operational Indicators
Competitive Positioning
Summary 5 Boehringer Ingelheim Promeco SA de CV: Competitive Position 2016
Farmacias Similares SA De Cv in Consumer Health (mexico)
Strategic Direction
Key Facts
Summary 6 Farmacias Similares SA de CV: Key Facts
Competitive Positioning
Summary 7 Farmacias Similares SA de CV: Competitive Position 2016
Genomma Lab Internacional Sab De Cv in Consumer Health (mexico)
Strategic Direction
Key Facts
Summary 8 Genomma Lab Internacional SAB de CV: Key Facts
Summary 9 Genomma Lab Internacional SAB de CV: Operational Indicators
Competitive Positioning
Summary 10 Genomma Lab Internacional SAB de CV: Competitive Position 2016
Executive Summary
Consumer Health Maintains Growth in 2016, Yet Slows Down
Mexicans Are Increasingly Buying Generics and Private Label
Multinationals Continue To Lead Consumer Health
Drugstores and Parapharmacies Gain Increasing Distribution Share
Consumer Health Set To Grow, But at Slower Pace Due To Higher Price Competition
Key Trends and Developments
Penetration of Generics and Private Label in the OTC Space on the Rise
New Players Define A Changing Distribution Landscape
Consumer Health Driven by Two Contrasting Trends: Wellness and Obesity
Market Indicators
Table 8 Consumer Expenditure on Health Goods and Medical Services: Value 2011-2016
Table 9 Life Expectancy at Birth 2011-2016
Market Data
Table 10 Sales of Consumer Health by Category: Value 2011-2016
Table 11 Sales of Consumer Health by Category: % Value Growth 2011-2016
Table 12 NBO Company Shares of Consumer Health: % Value 2012-2016
Table 13 LBN Brand Shares of Consumer Health: % Value 2013-2016
Table 14 Distribution of Consumer Health by Format: % Value 2011-2016
Table 15 Distribution of Consumer Health by Format and Category: % Value 2016
Table 16 Forecast Sales of Consumer Health by Category: Value 2016-2021
Table 17 Forecast Sales of Consumer Health by Category: % Value Growth 2016-2021
Appendix
OTC Registration and Classification
Vitamins and Dietary Supplements Registration and Classification
Self-medication/self-care and Preventive Medicine
Switches
Sources
Summary 11 Research Sources












View This Report »

Get Industry Insights. Simply.

  • Latest reports & slideshows with insights from top research analysts
  • 24 Million searchable statistics with tables, figures & datasets
  • More than 10,000 trusted sources
24/7 Customer Support

Talk to Veronica

+1 718 514 2762

Purchase Reports From Reputable Market Research Publishers
Over-the-Counter (OTC) Drugs and Dietary Supplements: Global Markets

Over-the-Counter (OTC) Drugs and Dietary Supplements: Global Markets

  • $ 6650
  • Industry report
  • March 2017
  • by BCC Research

Use this report to: - Receive information concerning the dynamics and forecasts in the OTC drugs and dietary supplements market - Receive information pertaining to the major regional trends in the global ...

U.S. Insomnia Market by Non-Pharmacological Therapy, Prescription Sleep Aids, Orexin Antagonist & OTC Treatment - Forecasts to 2021

U.S. Insomnia Market by Non-Pharmacological Therapy, Prescription Sleep Aids, Orexin Antagonist & OTC Treatment - Forecasts to 2021

  • $ 5650
  • Industry report
  • January 2017
  • by MarketsandMarkets

The U.S. insomnia market is projected to reach USD 4.24 billion by 2021 from USD 3.38 billion in 2016, growing at a CAGR of 4.6% from 2016 to 2021 In 2016, the cognitive behavioural therapy for insomnia ...

Global OTC Analgesics Market - Growth, Trends and Forecast (2017 - 2022)

Global OTC Analgesics Market - Growth, Trends and Forecast (2017 - 2022)

  • $ 4250
  • Industry report
  • February 2017
  • by Mordor Intelligence LLP

The global OTC Analgesics market accounted for a market value of USD XX billion in 2015. The market is expected to reach USD XX billion in 2016 and USD XX billion by 2021, growing at a CAGR of xx% during ...

Otc Drugs Markets In China

January 2017 $ 4000

Otc Drugs Companies In China

January 2017 $ 1800

Download Unlimited Documents from Trusted Public Sources

OTC Markets in the US

  • March 2017
    10 pages
  • Pancreatic Canc...  

    Vitamin  

  • United States  

View report >

OTC Industry in the US

  • March 2017
    89 pages
  • OTC  

  • United States  

View report >

OTC Supply in the US

  • March 2017
  • Dietary Supplem...  

  • United States  

View report >

Otc Markets In Europe

22 days ago

Otc Industry In China

23 days ago

Related Market Segments :

OTC
Acne Treatment

ref:plp2016

Reportlinker.com © Copyright 2017. All rights reserved.

ReportLinker simplifies how Analysts and Decision Makers get industry data for their business.